Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk

Internal Medicine Journal
Matthias Hermann, Frank Ruschitzka

Abstract

The introduction of selective cyclooxygenase-2 inhibitors offered the promise of similar efficacy in pain control without the gastrointestinal effects associated with non-selective non-steroidal anti-inflammatory drugs (NSAIDs). By blocking prostacyclin formation but leaving platelet-derived thromboxane A2 generation unopposed, there is concern that the potential gastrointestinal benefit of cyclooxygenase-2-selective inhibitors may come at the cost of increased thrombotic risk. However, the differential effects of coxibs on blood pressure, endothelial function, oxidative stress, tissue factor expression, vascular smooth muscle proliferation and neointimal hyperplasia indicate a distinct heterogeneity among this class of drugs. Importantly, the observation of an excess cardiovascular risk with traditional NSAIDs in randomized clinical trials, meta-analysis and large-scale observational studies further highlights the need to scrutinize the entire class of anti-inflammatory drugs, including traditional NSAIDs, as rigorously as coxibs.

Citations

Sep 28, 2007·Comprehensive Therapy·Wasim HaqueHarry L Messmore
Sep 4, 2010·Research in Social & Administrative Pharmacy : RSAP·Kent E M GrovesNeil J MacKinnon
Nov 14, 2006·Internal Medicine Journal·T Woodruff
Jul 5, 2007·The Annals of Pharmacotherapy·Javier C WaksmanScott D Phillips
Oct 3, 2014·Journal of Patient Safety·Cornelis A van den BogertKenneth G Saag
Dec 6, 2017·Postgraduate Medicine·Chris Walker, Luigi M Biasucci
Nov 14, 2007·International Journal of Clinical Practice·G I VarugheseM Reddy
Jul 29, 2010·Journal of Evaluation in Clinical Practice·Aneta PerićSandra Vezmar
Jan 24, 2007·The Journal of Pharmacology and Experimental Therapeutics·Fumitaka KamachiKazuo Ohuchi
Dec 16, 2010·Journal of Thrombosis and Haemostasis : JTH·R RisseladaM C J M Sturkenboom
Jan 21, 2021·Expert Opinion on Pharmacotherapy·Kevin S Tang, Ankur D Shah
Jul 15, 2021·Journal of Immunology Research·Shirin AssarJavier Echeverría
Dec 26, 2007·Bioorganic & Medicinal Chemistry·Aurelio OrjalesM Teresa Núñez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.